Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5940)
All Articles published online
|
Sep 14, 2012 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee JI, Lee JW, Kim JM, Kim JK, Chung HJ, Kim YS. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers. World J Gastroenterol 2012; 18(34): 4751-4757 [PMID: 23002345 DOI: 10.3748/wjg.v18.i34.4751] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i34/4751.htm |
| Number | Citing Articles |
| 1 |
Seo-Youn Choi, Seong Hyun Kim, Cheol Keun Park, Ji Hye Min, Ji Eun Lee, Yoon-Hyeong Choi, Bo Ra Lee. Imaging Features of Gadoxetic Acid–enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study. Radiology 2018; 286(3): 897 doi: 10.1148/radiol.2017162846
|
| 2 |
Sofia Zanotti, Gina F. Boot, Mairene Coto-Llerena, John Gallon, Gabriel F. Hess, Savas D. Soysal, Otto Kollmar, Charlotte K. Y. Ng, Salvatore Piscuoglio. The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.888850
|
| 3 |
KyuHo Lee, Kyoung-Bun Lee, Hae Yoen Jung, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Ja-June Jang. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3431-1
|
| 4 |
Jiatao Lou, LingFei Zhang, Shaogang Lv, Chenzi Zhang, Shuai Jiang. Biomarkers for Hepatocellular Carcinoma. Biomarkers in Cancer 2017; 9: 1179299X1668464 doi: 10.1177/1179299X16684640
|
| 5 |
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter. Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management. Liver Cancer 2024; 13(1): 6 doi: 10.1159/000530700
|
| 6 |
Changwu Zhou, Xiaoyan Ni, Xin Lu, Yi Wang, Xianling Qian, Chun Yang, Mengsu Zeng. MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma. Journal of Hepatocellular Carcinoma 2021; : 975 doi: 10.2147/JHC.S325686
|
| 7 |
Daniel E. Roberts, Sanjay Kakar, Neil Mehta, Ryan M. Gill. A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence. American Journal of Surgical Pathology 2018; 42(7): 855 doi: 10.1097/PAS.0000000000001053
|
| 8 |
Q. Qin, L.P. Deng, J. Chen, Z. Ye, Y.Y. Wu, Y. Yuan, B. Song. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis. Clinical Radiology 2023; 78(12): e975 doi: 10.1016/j.crad.2023.08.013
|
| 9 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_14-1
|
| 10 |
Jin‐Ping Lai, Andrew Conley, Beatrice S Knudsen, Maha Guindi. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. Histopathology 2015; 67(4): 442 doi: 10.1111/his.12623
|
| 11 |
Wei Shuyao, Bao Mingyang, Ma Feifei, Ha Xiaoqin. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC. Journal of Gastrointestinal Surgery 2022; 26(2): 341 doi: 10.1007/s11605-021-05107-w
|
| 12 |
Elizabeth Brunt, Shinichi Aishima, Pierre‐Alain Clavien, Kathryn Fowler, Zachary Goodman, Gregory Gores, Annette Gouw, Alex Kagen, David Klimstra, Mina Komuta, Fukuo Kondo, Rebecca Miksad, Masayuki Nakano, Yasuni Nakanuma, Irene Ng, Valerie Paradis, Young Nyun Park, Alberto Quaglia, Massimo Roncalli, Tania Roskams, Michiie Sakamoto, Romil Saxena, Christine Sempoux, Claude Sirlin, Ashley Stueck, Swan Thung, W.M.S. Tsui, Xin‐Wei Wang, Aileen Wee, Hirohisa Yano, Matthew Yeh, Yoh Zen, Jessica Zucman‐Rossi, Neil Theise. cHCC‐CCA. Hepatology 2018; 68(1): 113 doi: 10.1002/hep.29789
|
| 13 |
ELIENE BOGAERTS, FEMKE HEINDRYCKX, YVES-PAUL VANDEWYNCKEL, LEO A. VAN GRUNSVEN, HANS VAN VLIERBERGHE. The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours. International Journal of Oncology 2014; 44(4): 1015 doi: 10.3892/ijo.2014.2286
|
| 14 |
Long Yan, Feng Xie, Cheng Yang, Lihan Yu, Tao Zheng, Jun Fu, Jiamei Yang. The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0464-2
|
| 15 |
Florian Roßner, Bruno Valentin Sinn, David Horst. Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers 2023; 15(2): 494 doi: 10.3390/cancers15020494
|
| 16 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_6-1
|
| 17 |
Liqing Zhang, Heshan Zhou, Xiaoqian Zhang, Zhongxiang Ding, Jianfeng Xu. A radiomics nomogram for predicting cytokeratin 19–positive hepatocellular carcinoma: a two-center study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1174069
|
| 18 |
Shang-Dong Qin, Jie Zhang, Ya-Peng Qi, Jian-Hong Zhong, Bang-De Xiang. Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02632-z
|
| 19 |
Masayuki Akita, Tetsuo Ajiki, Takumi Fukumoto, Tomoo Itoh, Yoh Zen. Keratin 19‐expressing hepatocellular carcinoma and small‐duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features. Histopathology 2019; 75(3): 385 doi: 10.1111/his.13884
|
| 20 |
Xiaomei Zhuang, Gang Deng, Xiaoying Wu, Juping Xie, Dong Li, Songlin Peng, Di Tang, Guoying Zhou. Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143600
|
| 21 |
Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller, Karsten Gülow. HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1016952
|
| 22 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3 doi: 10.1007/978-3-319-26956-6_1
|
| 23 |
Ray-Hwang Yuan, Hong-Shiee Lai, Hey-Chi Hsu, Po-Lin Lai, Yung-Ming Jeng. Expression of Bile Duct Transcription Factor HNF1β Predicts Early Tumor Recurrence and Is a Stage-Independent Prognostic Factor in Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2014; 18(10): 1784 doi: 10.1007/s11605-014-2596-z
|
| 24 |
Ji Hae Nahm, Young Nyun Park. Up-to-date Knowledge on the Pathological Diagnosis of Hepatocellular Carcinoma. The Korean Journal of Gastroenterology 2021; 78(5): 268 doi: 10.4166/kjg.2021.140
|
| 25 |
Gregory Kenneth Muliawan, Terence Kin-Wah Lee. The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1400112
|
| 26 |
Aymeric Becq, Christian Mateescu, David Khayat, Mohamed Bouattour. Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid Adenocarcinoma. Medicine 2015; 94(27): e1101 doi: 10.1097/MD.0000000000001101
|
| 27 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06): 7 doi: 10.53879/id.56.06.11625
|
| 28 |
Morgan Preziosi, Minakshi Poddar, Sucha Singh, Satdarshan P. Monga. Hepatocyte Wnts Are Dispensable During Diethylnitrosamine and Carbon Tetrachloride-Induced Injury and Hepatocellular Cancer. Gene Expression 2018; 18(3): 209 doi: 10.3727/105221618X15205148413587
|
| 29 |
Yuying Chen, Jia Chen, Yu Zhang, Zhi Lin, Meng Wang, Lifei Huang, Mengqi Huang, Mimi Tang, Xiaoqi Zhou, Zhenpeng Peng, Bingsheng Huang, Shi-Ting Feng. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging. Journal of Hepatocellular Carcinoma 2021; : 795 doi: 10.2147/JHC.S313879
|
| 30 |
Dan-Dan Yu, Ying-Ying Jing, Shi-Wei Guo, Fei Ye, Wen Lu, Quan Li, Yu-Long Dong, Lu Gao, Yu-Ting Yang, Yang Yang, Meng-Chao Wu, Li-Xin Wei. Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma. Scientific Reports 2015; 5(1) doi: 10.1038/srep13319
|
| 31 |
Lorrane Viana, Rui Caetano Oliveira, Ricardo Martins, Henrique Alexandrino, Maria Augusta Cipriano, José Guilherme Tralhão. Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping. Gastrointestinal Disorders 2024; 6(2): 402 doi: 10.3390/gidisord6020027
|
| 32 |
Dalia Fahmy, Ahmed Alksas, Ahmed Elnakib, Ali Mahmoud, Heba Kandil, Ashraf Khalil, Mohammed Ghazal, Eric van Bogaert, Sohail Contractor, Ayman El-Baz. The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma. Cancers 2022; 14(24): 6123 doi: 10.3390/cancers14246123
|
| 33 |
Qian Wu, Yi‐xing Yu, Tao Zhang, Wen‐jing Zhu, Yan‐fen Fan, Xi‐ming Wang, Chun‐hong Hu. Preoperative Diagnosis of Dual‐Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models. Journal of Magnetic Resonance Imaging 2023; 57(4): 1185 doi: 10.1002/jmri.28391
|
| 34 |
Anne Menz, Rifka Bauer, Martina Kluth, Clara Marie von Bargen, Natalia Gorbokon, Florian Viehweger, Maximilian Lennartz, Cosima Völkl, Christoph Fraune, Ria Uhlig, Claudia Hube-Magg, Noémi De Wispelaere, Sarah Minner, Guido Sauter, Simon Kind, Ronald Simon, Eike Burandt, Till Clauditz, Patrick Lebok, Frank Jacobsen, Stefan Steurer, Waldemar Wilczak, Till Krech, Andreas H. Marx, Christian Bernreuther. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. Human Pathology 2021; 115: 19 doi: 10.1016/j.humpath.2021.05.012
|
| 35 |
Sunitta Saensa-ard, Saman Leuangwattanawanit, Laddawan Senggunprai, Nisana Namwat, Sarinya Kongpetch, Yaovalux Chamgramol, Watcharin Loilome, Walaiporn Khansaard, Apinya Jusakul, Auemduan Prawan, Chawalit Pairojkul, Narong Khantikeo, Puangrat Yongvanit, Veerapol Kukongviriyapan. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. Tumor Biology 2017; 39(11): 101042831772592 doi: 10.1177/1010428317725925
|
| 36 |
Mohamed Yousry Taher, Ehab Mostafa Hassouna, Abeer Shawky El-Hadidi, Omar Sameh El-aassar, Mohamed Fathy Bakosh. Predictive Value of Serum CYFRA 21-1 and CK19-2G2 for Tumor Aggressiveness and Overall Survival in Hepatitis C-Related Hepatocellular Carcinoma Among Egyptians: A Prospective Study. Journal of Gastrointestinal Cancer 2024; 55(2): 749 doi: 10.1007/s12029-023-01012-4
|
| 37 |
Joana Espírito Santo, Ana Ladeirinha, Ana Alarcão, Eugeniu Strelet, Marco Reis, Rui Santos, Lina Carvalho. Preoperative Locoregional Therapy May Relate with Stemness and Distinct Transitions Between Epithelial and Mesenchymal States in Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101268 doi: 10.1016/j.jceh.2023.08.004
|
| 38 |
Yu-Wen Zhou, Qing-Fang Li, Yue-Yun Chen, Kai Wang, Dan Pu, Xiao-Rong Chen, Chun-Hong Li, Li Jiang, Yan Wang, Qiu Li, Yu Yang, Hong-Feng Gou, Feng Bi, Ji-Yan Liu, Ye Chen, Meng Qiu. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study. European Journal of Surgical Oncology 2022; 48(7): 1559 doi: 10.1016/j.ejso.2022.01.023
|
| 39 |
Da-wei Sun, Ying-yi Zhang, Xiao-dong Sun, Yu-guo Chen, Wei Qiu, Min Ji, Guo-yue Lv. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis. Clinica Chimica Acta 2015; 448: 161 doi: 10.1016/j.cca.2015.06.027
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_1-1
|
| 41 |
Asmaa M. Elshaer, Omnyah A. El-kharashi, Ghada Galal Hamam, Enas S. Nabih, Yosra M. Magdy, Abeer A. Abd El Samad. Involvement of TLR4/ CXCL9/ PREX-2 pathway in the development of hepatocellular carcinoma (HCC) and the promising role of early administration of lactobacillus plantarum in Wistar rats. Tissue and Cell 2019; 60: 38 doi: 10.1016/j.tice.2019.07.010
|
| 42 |
Krishana Kumar Sharma, Mohd. Mohsin, Piyush Mittal, Zeeshan Ali, Nishat Fatma, Prashant Upadhyay, Ritu Gupta, Anurag Verma, Gajendra Kumar. Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review. Current Pharmaceutical Design 2024; 30(22): 1708 doi: 10.2174/0113816128298875240321073907
|
| 43 |
C. Martín-Sierra, R. Martins, P. Laranjeira, M. Coucelo, A.M. Abrantes, R.C. Oliveira, J.G. Tralhão, M.F. Botelho, E. Furtado, M.R. Domingues, A. Paiva. Functional and Phenotypic Characterization of Tumor-Infiltrating Leukocyte Subsets and Their Contribution to the Pathogenesis of Hepatocellular Carcinoma and Cholangiocarcinoma. Translational Oncology 2019; 12(11): 1468 doi: 10.1016/j.tranon.2019.07.019
|
| 44 |
Hongying Liu, Xieqi Wang, Bing Feng, Lipeng Tang, Weiping Li, Xirun Zheng, Ying Liu, Yan Peng, Guangjuan Zheng, Qinglian He. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4458-7
|
| 45 |
Jiliang Feng, Junmei Chen, Ruidong Zhu, Lu Yu, Yan Zhang, Dezhao Feng, Heli Kong, Chenzhao Song, Hui Xia, Jushan Wu, Dawei Zhao. Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection. Oncotarget 2017; 8(38): 63299 doi: 10.18632/oncotarget.18799
|
| 46 |
Pierre Bedossa, Valérie Paradis. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1272 doi: 10.1016/B978-0-323-34062-5.00089-3
|
| 47 |
Jianyong Zhuo, Di Lu, Zuyuan Lin, Xinyu Yang, Modan Yang, Jianguo Wang, Yaoye Tao, Xue Wen, Huihui Li, Zhengxing Lian, Beini Cen, Siyi Dong, Xuyong Wei, Haiyang Xie, Shusen Zheng, Youqing Shen, Xiao Xu. The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death & Disease 2021; 12(12) doi: 10.1038/s41419-021-04320-4
|
| 48 |
Haksier Ehedego, Mark V. Boekschoten, Wei Hu, Carina Doler, Johannes Haybaeck, Nikolaus Gaβler, Michael Müller, Christian Liedtke, Christian Trautwein. p21 Ablation in Liver Enhances DNA Damage, Cholestasis, and Carcinogenesis. Cancer Research 2015; 75(6): 1144 doi: 10.1158/0008-5472.CAN-14-1356
|
| 49 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 293 doi: 10.1007/978-3-319-26956-6_14
|
| 50 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 151 doi: 10.1007/978-3-319-26956-6_6
|
| 51 |
Jia-Feng Wu, Hsiu-Hao Chang, Meng-Yao Lu, Shiann-Tarng Jou, Kai-Chi Chang, Yen-Hsuan Ni, Mei-Hwei Chang. Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma. Journal of Biomedical Science 2017; 24(1) doi: 10.1186/s12929-017-0369-1
|
| 52 |
Subin Heo, Hyo Jeong Kang, Sang Hyun Choi, Sehee Kim, Youngeun Yoo, Won-Mook Choi, So Yeon Kim, Seung Soo Lee. Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M. European Radiology 2023; 34(5): 2974 doi: 10.1007/s00330-023-10305-y
|
| 53 |
Hong-Xian Gu, Xiao-Shan Huang, Jian-Xia Xu, Ping Zhu, Jian-Feng Xu, Shu-Feng Fan. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study. Journal of Digital Imaging 2023; 36(6): 2554 doi: 10.1007/s10278-023-00888-9
|
| 54 |
Violeta Zúñiga-García, María de Guadalupe Chávez-López, Valeria Quintanar-Jurado, Nayeli Belem Gabiño-López, Elisabeth Hernández-Gallegos, Juan Soriano-Rosas, Julio Isael Pérez-Carreón, Javier Camacho. Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development. Digestive Diseases and Sciences 2015; 60(8): 2373 doi: 10.1007/s10620-015-3633-9
|
| 55 |
Xialing Huang, Liling Long, Jieqin Wei, Yajuan Li, Yuwei Xia, Panli Zuo, Xiangfei Chai. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. Journal of Cancer Research and Clinical Oncology 2019; 145(12): 2995 doi: 10.1007/s00432-019-03062-3
|